Literature DB >> 24133081

Classification of encapsulating peritoneal sclerosis is important, but must encapsulate the entire spectrum of the disease.

Christopher J E Watson1, Andrew J Butler, J Andrew Bradley.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24133081      PMCID： PMC3797664          DOI： 10.3747/pdi.2013.00141

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  14 in total

1.  Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.

Authors:  P H Sugarbaker; K Kern; E Lack
Journal:  Dis Colon Rectum       Date:  1987-10       Impact factor: 4.585

Review 2.  Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences.

Authors:  Steven Guest
Journal:  Perit Dial Int       Date:  2009 May-Jun       Impact factor: 1.756

3.  Successful surgical management of encapsulating peritoneal sclerosis.

Authors:  Hideki Kawanishi; Hiroshi Watanabe; Misaki Moriishi; Shinichiro Tsuchiya
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

4.  Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?

Authors:  P M Allaria; A Giangrande; E Gandini; I B Pisoni
Journal:  J Nephrol       Date:  1999 Nov-Dec       Impact factor: 3.902

5.  Sclerosing peritonitis after CAPD.

Authors:  J A Bradley; D N Hamilton; D L McWhinnie; J D Briggs; B J Junor
Journal:  Lancet       Date:  1983-09-03       Impact factor: 79.321

6.  Surgical treatment of sclerosing peritonitis caused by practolol.

Authors:  B T Jackson
Journal:  Br J Surg       Date:  1977-04       Impact factor: 6.939

7.  Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management.

Authors:  W K Eltringham; H J Espiner; C W Windsor; D A Griffiths; J D Davies; H Baddeley; A E Read; R J Blunt
Journal:  Br J Surg       Date:  1977-04       Impact factor: 6.939

8.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

9.  Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.

Authors:  V C Gandhi; H M Humayun; T S Ing; J T Daugirdas; V R Jablokow; S Iwatsuki; W P Geis; J E Hano
Journal:  Arch Intern Med       Date:  1980-09

10.  Localized encapsulating peritoneal sclerosis constricting the terminal ileum--an unusual appearance requiring surgical intervention.

Authors:  Sayed M Habib; Sander M Hagen; Mario R Korte; Robert Zietse; Frank J M F Dor; Michiel G H Betjes
Journal:  Perit Dial Int       Date:  2013-06-03       Impact factor: 1.756
View more
  4 in total

1.  Towards standardized reporting in studies of encapsulating peritoneal sclerosis.

Authors:  Mark Lambie; Niko Braun; Simon J Davies
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

Review 2.  Designing Epidemiology Studies to Determine the Incidence and Prevalence of Encapsulating Peritoneal Sclerosis (EPS).

Authors:  Dorothea Nitsch; Andrew Davenport
Journal:  Perit Dial Int       Date:  2015-12       Impact factor: 1.756

3.  C-reactive protein levels in combination with abdominal CT scans is a useful tool to predict the macroscopic appearance in late-stage EPS patients prior to surgery.

Authors:  Daniel Kitterer; Stephan Segerer; Wolfgang Steurer; Juergen Dippon; Angela Geissler; Christoph Ulmer; Niko Braun; Mark Dominik Alscher; Joerg Latus
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-08-13

4.  Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.

Authors:  Graham Woodrow; Stanley L Fan; Christopher Reid; Jeannette Denning; Andrew Neil Pyrah
Journal:  BMC Nephrol       Date:  2017-11-16       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.